Evaluation of immunogenicity post two doses of inactivated SARS-CoV-2 vaccine, Covaxin after six months

We have evaluated the immunogenicity of two dose of Covaxin given at a one-month interval to two adult populations, i.e. COVID-19 naïve-vaccinated individuals (n = 118) and COVID-19 recovered individuals (n = 128) with the vaccination. The immune response in the study population were assessed at thr...

Full description

Bibliographic Details

Published in:	Human Vaccines & Immunotherapeutics
Main Authors:	Rima R. Sahay, Pragya D. Yadav, Ashok Nandapurkar, Rutuja Dhawde, Annasaheb Suryawanshi, Deepak Y. Patil, Anita M. Shete, Gajanan N. Sapkal, Milind Kulkarni, Yogesh K. Gurav, Gururaj R. Deshpande, Jagdevi S. Ghodke, Rajlaxmi Jain, Raj Hawale, Kaumudi Kalele, Jyoti Yemul, Pranita Gawande, Priya Abraham
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2022-12-01
Subjects:	sars-cov-2 covaxin adult population immunogenicity
Online Access:	http://dx.doi.org/10.1080/21645515.2022.2156753